Status:

UNKNOWN

Effects of a Cognitive Training Program With Game Elements Among ADHD

Lead Sponsor:

University of Fribourg

Collaborating Sponsors:

Paris West University Nanterre La Défense

Conditions:

ADHD

Eligibility:

All Genders

6-65 years

Phase:

NA

Brief Summary

This study examines the impact of cognitive training among participants with ADHD in Switzerland

Detailed Description

The main aim of the experimental study is to investigate cognitive functioning, behavioral and neural levels in ADHD, both before and after cognitive training where there has been the addition of moti...

Eligibility Criteria

Inclusion

  • \-
  • Participants fulfilling all of the following inclusion criteria are eligible for the study for the patients'group:
  • Age between 6 and 65 years' old
  • ADHD diagnostic by a specialist
  • IQ-score higher than 80 for adult according to (WAIS-IV; Wechsler, 2008) and for children and adolescents according to (WISC-IV; Wechsler, 2003)
  • Treatment with or without medication for ADHD
  • Computer and Internet connexion at home
  • Informed consent from participants and the legal guardian of the minors (under 14 years old) involved - as documented by signature (Appendix Informed Consent Form).
  • Participants fulfilling all of the following inclusion criteria are eligible for the study for the control group of healthy participants:
  • Age between 6 and 65 years' old
  • No ADHD diagnostic by a specialist
  • IQ-score higher than 80 for adult according to (WAIS-IV; Wechsler, 2008) and for children and adolescents according to (WISC-IV; Wechsler, 2003)
  • No medication treatment for ADHD
  • Informed consent from participants and the legal guardian of the minors involved - as documented by signature (Appendix Informed Consent Form).

Exclusion

  • Exclusion criteria
  • The exclusion criteria for the participants in the patient's group are:
  • Age younger than 6 and older than 65 years' old
  • No diagnosis of ADHD
  • IQ-score lower than 80 points according to (WAIS-IV; Wechsler, 2008) and for children and adolescents according to (WISC-IV; Wechsler, 2003)
  • No computer and Internet access at home
  • No written consent from participants and from the legal guardians of minors involved as less than 14 years old.
  • (7) FMRI exclusion: claustrophobia, Pregnancy known or suspected,metallic implants in their bodies (e.g: pacemakers, aneurism clips, metal Prosthetic, cochlear implant) (8) In case of suicidal risk, the participant is encouraged to consult the medical staff (9) Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant (10) Participation in another study on cognitive training (11) Previous enrolment into the current study (12) Enrolment of the investigator, his/her family members, employees and other dependent persons
  • The exclusion criteria for the participants in the control group of healthy participants are:
  • Age younger than 6 and older than 65 years' old
  • Diagnosis of ADHD or other mental disorders
  • IQ-score lower than 80 points according to (WAIS-IV; Wechsler, 2008) and for children and adolescents according to (WISC-IV; Wechsler, 2003)
  • No written consent from participants and from the legal guardians of minors involved (for participants under 14 years old)
  • FMRI exclusion: claustrophobia, Pregnancy known or suspected, metallic implants in their bodies (e.g: pacemakers, aneurism clips, metal Prosthetic, cochlear implant)
  • In case of suicidal risk, the participant is encouraged to consult the medical staff.
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Previous enrolment into the current study
  • Enrolment of the investigator, his/her family members, employees and other dependent persons

Key Trial Info

Start Date :

February 20 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT03799029

Start Date

February 20 2019

End Date

December 1 2023

Last Update

January 10 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dentz Amélie

Montreal, Quebec, Canada, 2000